Larvol Delta - Identification-of-Protein-Signatures-Tracking-Changes-of-Disease-Activity-of-PsA-Disease-Domains-and-Improvement-With-Deucravacitinib-Treatment-in-Phase-3-Clinical-Studies

Sotyktu (deucravacitinib) - BMS

https://acrconvergence2026.eventscribe.net/fsPopup.asp?PresentationID=1896694&mode=presInfo

Vinod Chandran, MD,PhD,MBBS,DM,FRCPC

Sep 8, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next